LENZ Therapeutics, Inc.

NasdaqGS:LENZ Stock Report

Market Cap: US$729.6m

LENZ Therapeutics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Eef Schimmelpennink

Chief executive officer

US$7.0m

Total compensation

CEO salary percentage8.7%
CEO tenure4yrs
CEO ownership0.2%
Management average tenure1yr
Board average tenure1yr

Recent management updates

Recent updates

Companies Like LENZ Therapeutics (NASDAQ:LENZ) Are In A Position To Invest In Growth

Jan 01
Companies Like LENZ Therapeutics (NASDAQ:LENZ) Are In A Position To Invest In Growth

LENZ Therapeutics: Time For A Pause

Nov 27

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 30

CEO Compensation Analysis

How has Eef Schimmelpennink's remuneration changed compared to LENZ Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$7mUS$607k

-US$50m

Sep 30 2024n/an/a

-US$61m

Jun 30 2024n/an/a

-US$69m

Mar 31 2024n/an/a

-US$74m

Dec 31 2023US$3mUS$537k

-US$70m

Sep 30 2023n/an/a

-US$56m

Dec 31 2022US$1mUS$508k

-US$11m

Compensation vs Market: Eef's total compensation ($USD6.98M) is above average for companies of similar size in the US market ($USD3.37M).

Compensation vs Earnings: Eef's compensation has increased whilst the company is unprofitable.

CEO

Eef Schimmelpennink (52 yo)

4yrs

Tenure

US$6,983,510

Compensation

Mr. Evert B. Schimmelpennink, also known as Eef, serves as Director of Pipeline Therapeutics, Inc. since February 2022. He serves as an Independent Director at Contineum Therapeutics, Inc. since January 20...

Leadership Team

NamePositionTenureCompensationOwnership
Evert Schimmelpennink
President4yrsUS$6.98m0.18%
$ 1.3m
James McCollum
Co-Founder & Directorno dataUS$365.01k2.26%
$ 16.5m
Daniel Chevallard
Chief Financial Officer1yrUS$3.17m0.012%
$ 84.6k
Marc Odrich
Chief Medical Officer1yrUS$2.04m0.36%
$ 2.6m
Domenick Porfidia
Vice President of Salesno datano datano data
David Murphy
Vice President of Marketingno datano datano data
Breianna Bowen
Vice President of Human Resourcesno datano datano data
Shawn Olsson
Chief Commercial Officer1yrUS$795.02k0.012%
$ 88.4k
Marvin Garrett
Senior Vice President of Regulatory & Qualityno datano datano data

1.0yrs

Average Tenure

58yo

Average Age

Experienced Management: LENZ's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Evert Schimmelpennink
President4yrsUS$6.98m0.18%
$ 1.3m
James McCollum
Co-Founder & Director1yrUS$365.01k2.26%
$ 16.5m
Shelley Thunen
Independent Director1yrUS$381.40k0%
$ 0
Terry Kim
Member of Medical Advisory Boardno datano datano data
Robert Osher
Member of Medical Advisory Boardno datano datano data
Colman Kraff
Member of Medical Advisory Boardno datano datano data
Steven Dell
Member of Medical Advisory Boardno datano datano data
John Doane
Member of Medical Advisory Boardno datano datano data
Jeffrey George
Independent Chairman1yrUS$396.22k0%
$ 0
Frederic Guerard
Independent Director1yrUS$380.23k0%
$ 0
Deepinder Dhaliwal
Member of Medical Advisory Boardno datano datano data
Zachary Scheiner
Independent Director4.4yrsno data0%
$ 0

1.0yrs

Average Tenure

51.5yo

Average Age

Experienced Board: LENZ's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/24 03:28
End of Day Share Price 2025/03/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LENZ Therapeutics, Inc. is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason Matthew GerberryBofA Global Research
Yigal NochomovitzCitigroup Inc
Matthew CaufieldH.C. Wainwright & Co.